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 The Use of Liver Microsome In-Vitro Methods to Study Toxicant 
Metabolism and Predict Species Efficacy 
 
Katherine E. Horak, Chad R. Wermager, and Thomas M. Primus  
USDA APHIS WS National Wildlife Research Center, Fort Collins, Colorado 
 
  Liver microsomes are used extensively in human pharmaceutical development to study the metabolism of 
compounds of interest; however, they are rarely part of the development of toxicants for the control of wildlife.  Liver microsome 
samples from wildlife of interest would likely be harvested in the field without access to laboratory perfusion equipment. Therefore, 
the metabolic activity of microsomes from perfused and non-perfused livers was compared.  There was no significant difference in 
diphacinone metabolism by liver microsomes from both perfused and non-perfused Wistar rat livers, although chlorophacinone 
metabolism was significantly different.  There are often significant differences in metabolism between species that can be utilized to 
increase toxicant specificity.  In this study bobwhite quail liver microsomes metabolized more diphacinone and chlorophacinone 
than both Wistar and brown rats.  This information can be used during toxicant development to help determine the most sensitive 
species to toxicants of interest.  Additionally, the effect of incubation time on toxicant metabolism was examined to determine 
optimal experimental conditions.  The data from these experiments support the use of liver microsomes as a tool to be used during 
toxicant development to provide information that can be incorporated into whole animal studies. 
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INTRODUCTION 
Many of the toxicants used to control wildlife, such as 
chlorophacinone, diphacinone, and zinc phosphide, are 
formulated for oral delivery.  Although this method is 
convenient and offers numerous benefits, drugs that are 
absorbed through the GI tract will, most often, pass 
through the portal circulation into the liver prior to 
reaching the site of action.  The liver is the major organ 
responsible for biotransformation and metabolism.  This 
metabolism serves to detoxify and ultimately eliminate 
chemicals from the body.  Efficient metabolism and 
elimination of toxicants serves as an evolutionary advan-
tage, but poses a major hurdle in wildlife toxicant 
development. 
 Toxicant metabolism is characterized by two types of 
enzymatic reactions, namely phase I and phase II.  Phase 
I reactions involve oxidation, reduction, or hydrolysis and 
are performed by a class of enzymes called cytochrome 
p450 (Klassen 2001).  These enzymes are located in the 
endoplasmic reticulum of many tissues but occur in very 
high density in the liver.  Metabolic reactions catalyzed 
by cytochrome p450 enzymes can reduce the toxicity of a 
compound by increasing its water solubility, thereby 
enhancing excretion.  Phase I reactions may also produce 
metabolites with greater toxicity than the parent 
compound.  These processes can be examined through 
the isolation of and experimentation using liver 
microsomes. 
Early knowledge regarding metabolic fate of potential 
toxicants for the control of wildlife population helps in 
the development process by allowing for the selection of 
the most promising candidates, based on criteria such as 
their efficacy, duration of action, or threat to non-target 
species.  By isolating liver microsomes, multiple in-vitro 
experiments can be performed to determine the extent of 
metabolism and possible interactions with other 
chemicals that have affinity for the same enzymes 
(Pelkonen et al. 1998, Wrighton et al. 1993).   
In addition to helping in the toxicant development 
process, liver microsomes can be used to assist in the 
determination of possible risks to non-target species.  
Often the metabolic profiles of species will differ, which, 
while it poses a problem in veterinary medicine, can be 
exploited during toxicant development (Lewis et al. 1998, 
Fink-Gremmels 2008).  If metabolic differences between 
target and a non-target species are identified, it remains 
possible to modify toxicants to increase toxicity to the 
species of interest, while decreasing risks to non-target 
species.   
Although much research has been done in the human 
health sciences using liver microsomes and metabolic 
determination, this line of research is just beginning to be 
used in wildlife management.  Unlike conventional 
laboratory settings, harvesting livers for microsome 
isolation from wildlife species often occurs in the field 
with limited availability to instrumentation, limiting the 
tissue preparation that could be done.  To test the viability 
of microsomes isolated using field techniques, a series of 
experiments were conducted to compare saline perfused 
and non-perfused microsomes.  Also, differences in 
metabolism between Wistar rats, brown rats, and 
bobwhite quail were investigated.  Finally, the effects of 
microsomal incubation time on total metabolism were 
characterized. 
   
METHODS  
Study Animals 
Livers were harvested from Wistar and brown rats 
(Rattus norvegicus) and bobwhite quail (Colinus virginia-
nus).  Following euthanasia by CO2, a longitudinal 
incision was made in the abdomen, and the liver was 
removed and weighed.  The tissue was rinsed thoroughly 
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 and either perfused with ice-cold 0.9% NaCl or 
immediately frozen in liquid nitrogen.  The perfusion was 
continued until the liver appeared blanched; the perfused 
tissue was then snap-frozen in liquid nitrogen.  The frozen 
samples were stored at -80 C until further processing.   
 
Test Solutions 
All test fortification formulations consisted of dipha-
cinone or chlorophacinone solutions at approximately 40 
ppm in phosphate (0.010 M) solutions buffered at a pH of 
7.4.  Solutions of magnesium chloride, phosphate buffer, 
and NADH were all 0.010 M.  Homogenization buffer 
was as follows: sucrose 250 mM, HEPES 50 mM, KCl 
25 mM, MgCl2 5 mM, EDTA 0.1 mM, adjust pH to 7.4.  
Cofactor solution was made by adding 11.5 mg NADP 
sodium salt, 5.2 mg glucose-6-phosphate, and 50 L 
glucose-6-phosphate dehydrogenase to 950 L 0.01 M 
MgCl in phosphate buffer.   
 
Liver Microsome Preparation 
Livers microsomes were isolated using differential 
centrifugation according to the method by Pelkonen et al. 
(1974) with minor alterations.  Frozen liver samples were 
minced, weighed, and transferred to a Teflon pestle/glass 
homogenizer with 2 volumes (w/v) homogenization 
buffer with the addition of phenylmethanesulfonyl 
fluoride (Sigma) 2.5 L/ mL homogenization buffer.  The 
tissue was homogenized with 6 passes of the Teflon 
pestle homogenizer (Wheaton Overhead Stirrer, Wheaton 
Science Products, Millville, NJ).  The homogenates were 
centrifuged at 10,000 g for 10 min at 4 C (Beckman 
Coulter Avanti J-301, Beckman Coulter Inc., Brea, CA).  
The supernatants were transferred to a clean centrifuge 
tube and spun at 15,000 g for 20 minutes at 4 C.  The 
supernatant was then transferred to ultracentrifuge tubes 
and spun at 105,000 g for 60 minutes at 4 C.  The pellets 
were then washed with approximately 1 mL homogeniza-
tion buffer, transferred to the Teflon pestle/glass 
homogenizer and resuspended in homogenization buffer 
(1 g w/ 0.8 mL vol), and spun at 105,000 g for 60 minutes 
at 4 C.  The supernatants were discarded, and the remain-
ing pellets were resuspended in homogenization buffer 
using Teflon pestle/glass homogenizer (1:1, w:v) and 
frozen at -80 C.   
 
Microsome Incubation 
Microsome incubations were performed using 50 L 
microsome extract, 50 L cofactor solution, the analyte, 
and 0.01 M phosphate buffer added to bring volume to 
500 L.  These incubations contained 2.4 ppm of either 
diphacinone or chlorophacinone.  Incubations were done 
at 37 C for 60 minutes unless otherwise noted. 
 
Residue Determination  
Chlorophacinone and diphacinone residue determina-
tion was completed by quenching 0.400 mL of the 
incubation solution with 0.600 mL of methanol 
containing 5 mM tetrabutylammonium phosphate and 
vortex mixing.  These samples are filtered with 0.45 µm 
Teflon syringe filters prior to analysis by reverse phase 
ion-pairing high performance liquid chromatography 
(HPLC) using the following parameters: 55:45 methanol: 
water w/5 mM tetrabutylammonium phosphate, 10 mM 
phosphate buffer @ pH = 8.5, octadecyl silane column 
150 mm × 3.0 mm particle size 3 µm at 0.300 mL/min at 
35 C, UV detection at 325 nm with UV spectral 
confirmation using an Agilient 1100 with ChemStation 
software (Agilent Technologies Inc., Santa Clara, CA).   
 
Statistical Methods 
Data are representative of 4 samples per group and are 
expressed as mean ± SEM. Data were tested for homo-
geneity of variance and normality.  The differences 
between groups were analyzed using Student’s t-test. 
 
RESULTS 
Metabolic activity of microsomes from both perfused 
and non-perfused Wistar rat livers was examined using 
both diphacinone and chlorophacinone as substrates 
(Figure 1).  Perfusion did not significantly affect the 
percent of diphacinone metabolized, although there was a 
significant difference in the amount of chlorophacinone 
metabolized between microsomes from the perfused 
livers (60% chlorophacinone metabolized) and non-
perfused livers (52% metabolized) (p = 0.05).  Compar-
ing perfused liver metabolism of chlorophacinone and 
diphacinone showed that more diphacinone is metabo-
lized than chlorophacinone.  Microsomes extracted from 
perfused livers metabolized 95% of diphacinone and only 
60% of chlorophacinone in the 60-minute incubation (p < 
0.01).  The same pattern occurred in microsomes from 
non-perfused livers, with 91% of diphacinone being 
metabolized and 52% of chlorophacinone (p < 0.01).  
 
*  p = 0.002 compared to perfused diphacinone metabolism.  
† p = 0.006 compared to non-perfused diphacinone metabolism.  
‡:p = 0.05 compared to perfused chlorophacinone metabolism. 
Figure 1.  Percent diphacinone metabolized (average ± 
SEM) in incubations using liver microsomes from 
perfused and non-perfused Wistar rat livers.  
 
To investigate species differences in metabolism, liver 
microsomes from Wistar rats, brown rats, and bobwhite 
quail were incubated with diphacinone and chlorophaci-
none (Figure 2).  Wistar rats metabolized significantly 
less chlorophacinone than both brown rats and bobwhite 
quail (53%, 66%, and 71% respectively, p < 0.05).  The 
same trend was true for diphacinone, although the 
difference in metabolism is only significant between 
Wistar rats and bobwhite quail, with Wistar rats meta-
bolizing 78% of the diphacinone, brown rats metabolizing 
86%, and bobwhite quail metabolizing 93% (p < 0.05).  
* †‡ 
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 In each species tested, the metabolism of diphacinone 
was significantly higher than that of chlorophacinone.  
Wistar rats had a difference in metabolism between 
diphacinone and chlorophacinone of 25%, in brown rats 
the difference was 20%, and in bobwhite quail the 
difference was 22% (p < 0.05). 
 
 p < 0.05 compared to Wistar rat metabolism 
Figure 2.  Percent diphacinone and chlorophacinone 
metabolized by liver microsomes from Wistar rats, brown 
rats, and bobwhite quail.  
 
Figure 3.  Time course study comparing percent of 
diphacinone metabolized by Wistar rat and bobwhite quail 
microsomes following 30, 60, 90, and 120 minutes of 
incubation. 
 
The effect of incubation time on amount of 
diphacinone metabolized was investigated using both 
Wistar rats and bobwhite quail.  As incubation time 
increased so did the percent of diphacinone metabolized, 
from 60% after 30 minutes of incubation to 83% 
following 120 minutes of incubation.  The bobwhite quail 
data showed the same increase in percent metabolized 
with increasing incubation time.  After 30 minutes of 
incubation, bobwhite quail metabolized 61% of the 
diphacinone, increasing to 90% with 120 minutes of 
incubation (Figure 3). 
 
DISCUSSION 
For liver microsomes to be a beneficial tool used in 
the development of compounds for the control of wildlife, 
livers must often be harvested in the field where access to 
laboratory equipment is limited.  Specifically, it would be 
beneficial if livers could be harvested in the field without 
the burden of tissue perfusion with saline.  Therefore, the 
metabolic activity of microsomes from non-perfused 
livers was compared with those harvested using the 
traditional perfusion methodology.  There was not a 
significant difference in diphacinone metabolism between 
the two groups, although there was a significant differ-
ence in chlorophacinone metabolism.  The important in-
formation from microsome experiments used in toxicant 
development is the relative amount of metabolism of 
various compounds.  There was no significant difference 
in the ratios of chlorophacinone to diphacinone metabo-
lized between perfused and non-perfused liver micro-
somes (data not shown).  Since comparisons of the 
metabolism of chemicals used for control would, in 
theory, be performed with non-perfused livers, the 
difference in metabolism between perfused and non-
perfused would not affect results.  Use of microsomes 
from non-perfused livers will still enable researchers to 
screen possible toxicants to streamline the development 
process.  By eliminating the perfusion step, harvesting 
livers for subsequent microsome extraction becomes a 
technique that can realistically be done by technicians in 
the field with little additional training.   
It is possible to study the metabolic profiles of a wide 
variety of animals through the use of liver microsomes.  
These in-vitro experiments enable researchers to study 
multiple compounds of interest without the burden of 
numerous liver animal studies.  An example of this is the 
series of experiments comparing the metabolism of 
diphacinone and chlorophacinone in Wistar rats, brown 
rats, and bobwhite quail.  It is evident that more 
diphacinone than chlorophacinone was metabolized 
under the same conditions in all of the species studies.  
Although there are wide variations in the published 
toxicity data, these results are congruent, with the Wistar 
rat LD50 for diphacinone (7.0 mg/kg) being higher than 
that for chlorophacinone (3.15 mg/kg) (Fishel 2005, 
reviewed in Eisemann and Swift 2006).  These 
differences in toxicity are what would be predicted using 
only the liver microsome data.  Since more of the 
diphacinone than chlorophacinone is metabolized, it 
follows that diphacinone would be less toxic.   
In addition to mirroring the differences between in-
vivo toxicity of diphacinone and chlorophacinone, liver 
microsome data also demonstrate differences in species 
toxicity.  In the liver microsome experiments, bobwhite 
quail metabolized 15% more diphacinone and 18% more 
chlorophacinone that Wistar rats, with brown rat 
microsome metabolism at an intermediate level between 
the two.  These in-vitro data indicate that both dipha-
cinone and chlorophacinone should be less toxic to 
bobwhite quail than rats; this is the trend that is found in 
whole animal toxicity tests that report an LD50 for 
bobwhite quail between 400 and 2,000 mg/kg, with rat 
LD50 being 10 to 100 times higher (US EPA 1998, 
reviewed in Eisemann and Swift 2006).  The ability to 
compare relative toxicities between species is important 
during toxicant development, as this information can be 
used to direct future whole animal toxicity tests to include 
the more sensitive species. 
One of the variables that must be considered when
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 conducting microsome incubations is the amount of time 
the microsomes are incubated with the compound of 
interest.  If the incubation time it too short, possible 
differences in metabolic activity may not be evident 
(Figure 3).  To determine the differences in metabolism 
between Wistar rats and bobwhite quail, it is important to 
allow the microsomes to metabolize the diphacinone for 
more than 60 minutes to detect differences.  If the micro-
some experiments were terminated after 30 minutes, 
information about the distinct metabolic profiles would be 
lost. 
Advances are being made to use data from liver 
microsome experiments to estimate metabolism and 
therefore in-vivo doses.  Most of the work to date has 
been aimed at predicting drug clearance in humans, 
although many of these studies use preclinical animal 
data (Riley et al. 2005, Boxenbaum 1982).  Many papers 
have been published concerning the allometric scaling of 
data from microsome studies to in-vivo dosing and 
clearance (Obach 1999).  Although little work has been 
done to scale microsome data to whole animal drug 
clearance and toxicity in wildlife, this area of research 
shows promise in helping scientists choose compounds 
for further development.  The ability to estimate starting 
doses for in-vivo toxicity tests will not only save time and 
money for investigators, but it also could decrease the 
number of experimental animals used to determine 
toxicity levels. 
 
ACKNOWLEDGEMENTS 
The authors would like to acknowledge Gary Witmer for providing 
liver tissue for many of these experiments.  The authors also thank 
Bruce Kimball for helpful revisions of this manuscript.  All animal 
procedures were approved by the Institutional Animal Care and Use 
Committees of the USDA National Wildlife Research Center.   
 
LITERATURE CITED 
BOXENBAUM, H.  1982.  Interspecies scaling, allometry, 
physiological time and the ground plan of pharmaco-
kinetics.  J. Phramacokinet. Biopharm. 10:201-227. 
EISEMANN, J. D., and C. E. SWIFT.  2006.  Ecological and 
human health hazards from broadcast application of 0.005% 
diphacinone rodenticide baits in native Hawaiian 
ecosystems.  Proc. Vertebr. Pest Conf. 22:413-433. 
FINK-GREMMELS, J.  2008.  Implications of hepatic cytochrome 
P450-related biotransformation processes in veterinary 
sciences.  Eur. J. Pharmacol. 585:502-509. 
FISHEL, F. M.  2005.  Pesticide toxicity profile: Coumarin and 
indandione rodenticides.  Extension Publication PI-76, 
Institute of Food and Agricultural Sciences, Univ. of 
Florida.  4 pp. 
KLASSEN, C. D. (EDITOR).  2001.  Casarett and Doull’s 
Toxicology – The Basic Science of Poisons, 6th Ed.  
McGraw-Hill, New York, NY.  1,236 pp. 
LEWIS, D. F. V., C. LOANNIDES, and D. V. PARKE.  1998.  
Cytochrome P450 and species differences in xenobiotic 
metabolism and activation of carcinogen.  Environ. Health 
Perspect. 106:633-640. 
OBACH, R. S.  1999.  Prediction of human clearance of twenty-
nine drugs from hepatic microsomal intrinsic clearance 
data: An examination of in vitro half-life approach and 
nonspecific binding to microsomes.  Drug Metab. Disposit. 
27:1350-1359. 
PELKONEN, O., E. H. KALTIALA, T. K. I. LARMI, and N. T. 
KÄRKI.  1974.  Cytochrome P-450-linked monooxygenase 
system and drug-induced spectral interactions in human 
liver microsomes.  Chem.-Biol. Interact. 9:205-216. 
PELKONEN, O., J. MÄENPÄÄ, P. TAAVITSAINEN, A. RAUTIO, and 
H. RAUNIO.  1998.  Inhibition and induction of human 
cytochrome P450 (CYP) enzymes.  Xenobiotica 28:1203-
1253. 
RILEY, R., D. F. MCGINNITY, and R. P. AUSTIN.  2005.  A 
unified model for predicting human hepatic, metabolic 
clearance from in-vitro intrinsic data in hepatocytes and 
microsomes.  Drug Metab. Disposit. 33:1304-1311. 
US EPA.  1998.  Reregistration eligibility decision (RED): 
Rodenticide cluster.  EPA 738-R-98-007, U.S. 
Environmental Protection Agency, Washington, DC.  
http://www.epa.gov/oppsrrd1/REDs/2100red.pdf. 
WRIGHTON, S. A., M. VANDENBRANDEN, J. C. STEVENS, L. A. 
SHIPLEY, F. J. RING, A. E. RETTIE, and J. R. CASHMAN.  
1993.  In vitro methods for assessing human hepatic drug 
metabolism: Their use in drug development.  Drug Metab. 
Rev. 25:453-484. 
 
198
